Suchergebnisse - "Suman, Vera J"

PubPharm (315)

1

Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

enthalten in: JAMA | 2024

von Leon-Ferre, R. | Jonas, S. | Salgado, R. | +31

2

Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancer

enthalten in: NPJ breast cancer | 2024

von Leon-Ferre, R. | Carter, J. | Zahrieh, D. | +12

3

A Phase I trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Kalogera, E. | Nevala, W. | Finnes, H. | +21

4

Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort

enthalten in: Clinical pharmacology and therapeutics | 2024

von Mc Laughlin, A. | Helland, T. | Klima, F. | +74

5

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination : A Phase 3 Randomized Clinical Trial

enthalten in: JAMA oncology | 2024

von Ma, C. | Suman, V. | Sanati, S. | +27

6

Breast Cancer Risk Perceptions Among Underserved, Hispanic Women : Implications for Risk-Based Approaches to Screening

enthalten in: Journal of racial and ethnic health disparities | 2024

von Austin, J. | Jenkins, S. | Suman, V. | +8

7

Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma : the Phase II NeoACTIVATE trial

enthalten in: Nature communications | 2024

von Hieken, T. | Nelson, G. | Flotte, T. | +21

8

Integration of multi-omics data shows downregulation of mismatch repair, purin, and tubulin pathways in triple-negative chemotherapy-resistant breast tumors

enthalten in: ResearchSquare.com | 2023

von Tang, X. | Thompson, K. | Kalari, K. | +12

9

Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer : The Phase 2 TBCRC041 Randomized Clinical Trial

enthalten in: JAMA oncology | 2023

von Haddad, T. | Suman, V. | D'Assoro, A. | +20

10

Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors

enthalten in: Breast cancer research : BCR | 2023

von Tang, X. | Thompson, K. | Kalari, K. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[32]